Hemophilia A gene therapy

· Shanghai Xinzhi BioMed Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hemophilia A gene therapy, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs [Phase 2, Phase 3]